Conference Coverage
Conference Coverage
Chronic headache pain in veterans linked to suicide attempts
U.S. veterans with chronic headache pain had an increased risk of attempting suicide compared with vets with chronic neck or back pain,...
Conference Coverage
Mavrilimumab may aid severe COVID-19 recovery
The granulocyte/macrophage-colony stimulating factor (GM-CSF) blocker reduced the need for mechanical ventilation and death by day 29 versus...
Conference Coverage
Red meat intake tied to higher coronary heart disease risk
Substituting plant protein for red or processed meat was associated with reduced risk for fatal CHD, especially in women.
Conference Coverage
e-TNS device passes at-home test
A phase 3 study showed the Cefaly device was particularly effective against most bothersome migraine symptoms.
Conference Coverage
A large proportion of migraine patients are not offered preventive treatment
Among patients eligible for preventive therapy, more than a third were not offered this option, fewer than 10% were currently taking preventive...
Conference Coverage
Novel study links air pollution to increased risk of rheumatoid arthritis flares
Increased air pollution parallels increased RA flares in a novel study undertaken in an industrial city.
Conference Coverage
Patients with RA on rituximab at risk for worse COVID-19 outcomes
Risk mitigation strategies such as social distancing and wearing masks, especially indoors, remain important for people being treated with...
Conference Coverage
Combination therapy may benefit patients with migraine
A retrospective chart review suggests adding an anti-CGRP antibody to onabotulinumtoxinA boosts benefit.
Conference Coverage
VENUS: Ustekinumab appears superior to vedolizumab for refractory Crohn’s disease
“This study adds to the literature, aiming to position these newer biologics in the treatment algorithm,” Dr. Farrah Monzur said.
Conference Coverage
‘Remarkable’ response to diabetes drug in resistant bipolar depression
Patients with treatment-resistant bipolar depression with insulin resistance showed marked improvement in depressive symptoms after metformin...
Conference Coverage
Prebiotic in development shows promise for reducing GERD symptoms
A prebiotic therapy in development significantly reduced the number of days per month that people with gastroesophageal reflux disease experienced...